As Market Sorts Out AI, I’m Playing 2 Small-Cap Biotechs
I’ve got two biopharma stocks on my radar ahead of earnings.
Investors Are Nervous. I’m Getting Interested.
Dislocations driven by market conditions rather than fundamentals are creating my shopping list.
Apple Is the One Bright Spot on a ‘Dismal’ Day. This Is Why.
Here’s what bothers me most about this market and four names I’m eyeing on pullbacks.
I Don’t Know About You, But I’m Feeling These 22 Biotech Stocks
The market is in a transitional phase as we await earnings.
Stock Picking Is Working as Mag 7 and Chips Battle. Here’s What I’m Trading.
I’m heavily weighted in this one sector, while adding to one name on news.
I’m Selling Into Strength, But Watching This High-Risk/High-Return Stock
Here’s how I’m playing a solid reaction to the Iran deal but no euphoria.
Morgan Stanley Deal Makes it a Good Time to Add to This Biotech Name
A $23 million move by the small-cap concern has me looking to increase my position.
I’m Eyeing 3 Names Amid Market Rotation
Here’s my strategy as the Dow rises as cash rotates out of overbought semiconductor stocks.
AI Rotation Props Up Indices But the Underlying Action Is Concerning
I’m upping the defense as I don’t like what I see.